Justin Chun

2.3k total citations
35 papers, 1.7k citations indexed

About

Justin Chun is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Justin Chun has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Nephrology and 6 papers in Immunology. Recurrent topics in Justin Chun's work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (6 papers) and Renal and related cancers (6 papers). Justin Chun is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (6 papers) and Renal and related cancers (6 papers). Justin Chun collaborates with scholars based in Canada, United States and Chile. Justin Chun's co-authors include Daniel A. Muruve, Paul L. Beck, Akosua Vilaysane, Kiril Trpkov, Sharon A. Clark, Paul Melançon, Brenda R. Hemmelgarn, Mark E. Seamone, Rick Chin and Simon A. Hirota and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Justin Chun

32 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin Chun Canada 17 1.1k 507 361 260 220 35 1.7k
Julia Lichtnekert Germany 23 661 0.6× 501 1.0× 813 2.3× 62 0.2× 177 0.8× 34 1.8k
Marinka A.H. Bakker Netherlands 26 861 0.8× 640 1.3× 333 0.9× 598 2.3× 141 0.6× 45 2.1k
Tonya Watkins United States 22 814 0.7× 147 0.3× 319 0.9× 144 0.6× 203 0.9× 37 1.5k
Sonia Carta Italy 22 1.5k 1.3× 164 0.3× 1.0k 2.8× 62 0.2× 241 1.1× 37 2.2k
Wilco P. Pulskens Netherlands 15 734 0.7× 386 0.8× 565 1.6× 33 0.1× 265 1.2× 18 1.6k
Taro Horino Japan 20 581 0.5× 332 0.7× 174 0.5× 56 0.2× 202 0.9× 117 1.5k
Lori Broderick United States 21 1.5k 1.3× 174 0.3× 960 2.7× 116 0.4× 248 1.1× 50 2.5k
Robert A. Matthijsen Netherlands 13 432 0.4× 97 0.2× 299 0.8× 161 0.6× 269 1.2× 23 1.2k
Arthur Lau Canada 12 587 0.5× 183 0.4× 316 0.9× 45 0.2× 128 0.6× 23 992

Countries citing papers authored by Justin Chun

Since Specialization
Citations

This map shows the geographic impact of Justin Chun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Chun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Chun more than expected).

Fields of papers citing papers by Justin Chun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Chun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Chun. The network helps show where Justin Chun may publish in the future.

Co-authorship network of co-authors of Justin Chun

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Chun. A scholar is included among the top collaborators of Justin Chun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Chun. Justin Chun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lau, Arthur, Afshin Derakhshani, Graciela Andonegui, et al.. (2025). The spleen tyrosine kinase inhibitor entospletinib resolves inflammation to promote repair following acute kidney injury. JCI Insight. 10(16).
2.
Arutyunova, Elena, Heather Armstrong, Sadhna Phanse, et al.. (2025). Rhomboid protease GlpG regulates type 1 pili quality control and virulence in pathogenic E. coli. Nature Communications. 17(1). 968–968.
3.
Vandal, Milène, Mohsen Janmaleki, Jeff Biernaskie, et al.. (2025). CD2AP at the junction of nephropathy and Alzheimer’s disease. Molecular Neurodegeneration. 20(1). 63–63.
5.
Kitzler, Thomas M. & Justin Chun. (2023). Understanding the Current Landscape of Kidney Disease in Canada to Advance Precision Medicine Guided Personalized Care. Canadian Journal of Kidney Health and Disease. 10. 1035109385–1035109385. 8 indexed citations
6.
Wu, Jo‐Hsuan, et al.. (2022). Ocular involvement in TEMPI syndrome. American Journal of Ophthalmology Case Reports. 26. 101534–101534. 2 indexed citations
7.
Lau, Arthur, Jennifer J. Rahn, Hyunjae Chung, et al.. (2022). Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury. Science Advances. 8(5). eabm0142–eabm0142. 62 indexed citations
8.
Rahmani, Waleed, Hyunjae Chung, Sarthak Sinha, et al.. (2022). Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. iScience. 25(2). 103818–103818. 19 indexed citations
9.
Chung, Hyunjae, et al.. (2022). Infecting kidney organoids with a cDNA reporter clone of SARS-CoV-2. STAR Protocols. 3(3). 101617–101617. 4 indexed citations
10.
Chung, Hyunjae, Takanori Komada, Arthur Lau, et al.. (2021). AIM2 Suppresses Inflammation and Epithelial Cell Proliferation during Glomerulonephritis. The Journal of Immunology. 207(11). 2799–2812. 11 indexed citations
11.
Chung, Hyunjae, Daniel A. Muruve, Braedon McDonald, et al.. (2021). Post-mortem molecular investigations of SARS-CoV-2 in an unexpected death of a recent kidney transplant recipient. American Journal of Transplantation. 21(7). 2590–2595. 1 indexed citations
12.
Iftikhar, Mustafa, et al.. (2020). Epidemiology and outcomes of hyphema: a single tertiary centre experience of 180 cases. Acta Ophthalmologica. 99(3). e394–e401. 5 indexed citations
13.
Chun, Justin, et al.. (2020). Autosomal Dominant Tubulointerstitial Kidney Disease—Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease. Kidney International Reports. 5(4). 519–529. 14 indexed citations
14.
Bracey, Nathan A., Jaye M. Platnich, Arthur Lau, et al.. (2020). Tissue-selective alternate promoters guide NLRP6 expression. Life Science Alliance. 4(3). e202000897–e202000897. 6 indexed citations
15.
Wang, Minxian, Justin Chun, Giulio Genovese, et al.. (2019). Contributions of Rare Gene Variants to Familial and Sporadic FSGS. Journal of the American Society of Nephrology. 30(9). 1625–1640. 35 indexed citations
16.
Chung, Hyunjae, Akosua Vilaysane, Arthur Lau, et al.. (2016). NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis. Cell Death and Differentiation. 23(8). 1331–1346. 91 indexed citations
17.
Chun, Justin, Hyunjae Chung, Xiangyu Wang, et al.. (2016). NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA Nephropathy. Scientific Reports. 6(1). 24667–24667. 57 indexed citations
18.
Chun, Justin, et al.. (2010). Arf3 Is Activated Uniquely at thetrans-Golgi Network by Brefeldin A-inhibited Guanine Nucleotide Exchange Factors. Molecular Biology of the Cell. 21(11). 1836–1849. 41 indexed citations
19.
Vilaysane, Akosua, Justin Chun, Mark E. Seamone, et al.. (2010). The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD. Journal of the American Society of Nephrology. 21(10). 1732–1744. 480 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026